Private Equity | CCC Interim Leadership – MedTech & Life Sciences
Interim leadership for PE-backed MedTech, Medical Devices and Life Sciences companies
Operational stabilisation, scaling and transparent execution in critical phases
PE-backed MedTech, Medical Devices and Life Sciences companies are often under significant pressure – following a post-deal situation, during a turnaround or in a critical growth phase. In these situations, it is not the investment thesis itself, but its operational execution that determines value creation, trust and exit readiness.
CCC Interim Leadership provides interim leadership where experienced, execution-focused leadership is required at short notice – with a clear focus on stabilisation, structure and measurable operational results.
My role in a Private Equity context
I take on strategic and operational leadership responsibility in PE-backed MedTech, Medical Devices and Life Sciences companies when internal management capacity is insufficient or transition situations require clarity and direction.
My contribution is not deal execution, but interim leadership after the deal:
- Safeguarding ongoing business performance
- Ensuring transparency and reliability for investors and boards
- Building robust structures for scaling and exit readiness
···
Typical engagement situations where I add value
Post-deal stabilisation & operational interim leadership
Immediately after closing, I assume operational responsibility, create orientation and ensure the organisation remains fully capable of execution.
Key focus areas:
- Stabilising revenue, customer relationships and delivery capability
- Establishing clear leadership, decision-making and governance structures
- Structured, transparent communication with investors and governance bodies
···
Carve-outs & public-to-private transitions
In business units or companies separated from corporate or publicly listed structures, my focus is on operational stability and the establishment of robust, independent organisations.
Core responsibilities:
- Stabilising revenue streams and customer relationships
- Building independent organisations with clear roles and accountability
- Implementing PE-ready steering and reporting frameworks
···
Scaling and value creation phases
- Structuring growth without operational overload
- Sharpening go-to-market, commercial and operating models
- Implementing robust KPI and reporting systems
- Preparing the organisation for the next ownership phase or exit
Industry focus
- MedTech & Medical Devices
- Life Sciences & adjacent services
- Healthcare-related technologies with a strong industrial foundation
I work exclusively in sectors where regulatory requirements, market dynamics and operational reality must be fully understood – and where interim leadership delivers impact in day-to-day execution.
Approach & expectations
Impact does not come from standard solutions, but from:
- Clear prioritisation instead of actionism
- Structured 90-/100-day agendas
- Methodical execution across defined impact areas
- Leadership with clarity, integrity and accountability
The objective is always an organisation that remains independently effective after the interim mandate.